Sastasundar Ventures [SASTASUNDR] vs Dipna Pharmachem [DPL] Detailed Stock Comparison

Sastasundar Ventures Ltd.

NSE
Loading...

Dipna Pharmachem Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sastasundar Ventures Ltd. wins in 6 metrics, Dipna Pharmachem Ltd. wins in 12 metrics, with 0 ties. Dipna Pharmachem Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sastasundar Ventures Ltd. Dipna Pharmachem Ltd. Better
P/E Ratio (TTM) 33.04 10.09 Dipna Pharmachem Ltd.
Price-to-Book Ratio 1.26 0.35 Dipna Pharmachem Ltd.
Debt-to-Equity Ratio 0.59 23.42 Sastasundar Ventures Ltd.
PEG Ratio -0.32 N/A N/A
EV/EBITDA 1,310.12 8.55 Dipna Pharmachem Ltd.
Profit Margin (TTM) 2.04% 1.92% Sastasundar Ventures Ltd.
Operating Margin (TTM) 0.30% 2.34% Dipna Pharmachem Ltd.
EBITDA Margin (TTM) 0.30% 2.34% Dipna Pharmachem Ltd.
Return on Equity -10.55% 4.24% Dipna Pharmachem Ltd.
Return on Assets (TTM) -9.36% 1.59% Dipna Pharmachem Ltd.
Free Cash Flow (TTM) $-276.65M $-92.15M Dipna Pharmachem Ltd.
Dividend Yield N/A 23.16% N/A
1-Year Return 0.57% -68.24% Sastasundar Ventures Ltd.
Price-to-Sales Ratio (TTM) 0.68 0.21 Dipna Pharmachem Ltd.
Enterprise Value $10.51B $338.55M Sastasundar Ventures Ltd.
EV/Revenue Ratio 0.82 0.32 Dipna Pharmachem Ltd.
Gross Profit Margin (TTM) 7.70% 44.45% Dipna Pharmachem Ltd.
Revenue per Share (TTM) $401 $45 Sastasundar Ventures Ltd.
Earnings per Share (Diluted) $8.19 $0.86 Sastasundar Ventures Ltd.
Beta (Stock Volatility) 0.37 -0.17 Dipna Pharmachem Ltd.

Sastasundar Ventures Ltd. vs Dipna Pharmachem Ltd. Stock Performance Analysis

Loading Price Chart...

SASTASUNDR
DPL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sastasundar Ventures Ltd.0.90%-7.90%-0.76%-0.39%-6.65%-4.75%
Dipna Pharmachem Ltd.2.00%-10.08%-4.80%-24.84%-48.60%-58.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sastasundar Ventures Ltd.0.57%-2.95%-7.26%307.99%612.04%173.38%
Dipna Pharmachem Ltd.-68.24%-97.06%-96.96%-92.04%-93.84%-93.84%

Performance & Financial Health Analysis: Sastasundar Ventures Ltd. vs Dipna Pharmachem Ltd.

MetricSASTASUNDRDPL
Market Information
Market Cap i₹8.58B₹228.19M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i11,32745,900
90 Day Avg. Volume i13,83351,200
Last Close₹280.90₹7.14
52 Week Range₹252.50 - ₹363.00₹6.66 - ₹25.66
% from 52W High-22.62%-72.17%
All-Time High₹580.00 (Jan 10, 2022)₹558.00 (Jan 29, 2024)
% from All-Time High-51.57%-98.72%
Growth Metrics
Quarterly Revenue Growth0.33%-0.20%
Quarterly Earnings Growth0.22%3.19%
Financial Health
Profit Margin (TTM) i0.02%0.02%
Operating Margin (TTM) i0.00%0.02%
Return on Equity (TTM) i-0.11%0.04%
Debt to Equity (MRQ) i0.5923.42
Cash & Liquidity
Book Value per Share (MRQ)₹214.21₹24.62
Cash per Share (MRQ)₹7.44₹0.29
Operating Cash Flow (TTM) i₹-124,301,000₹-140,640,000
Levered Free Cash Flow (TTM) i₹-911,671,000₹-160,558,752
Dividends
Last 12-Month Dividend Yield iN/A23.16%
Last 12-Month Dividend i₹0.00₹5.00

Valuation & Enterprise Metrics Analysis: Sastasundar Ventures Ltd. vs Dipna Pharmachem Ltd.

MetricSASTASUNDR (Apr 24, 2026)DPL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i33.0410.09
Forward P/E i-15.28N/A
PEG Ratio i-0.32N/A
Price to Sales (TTM) i0.680.21
Price to Book (MRQ) i1.260.35
Market Capitalization
Market Capitalization i₹8.58B₹228.19M
Enterprise Value i₹10.51B₹338.55M
Enterprise Value Metrics
Enterprise to Revenue i0.820.32
Enterprise to EBITDA i1,310.128.55
Risk & Other Metrics
Beta i0.37-0.17
Book Value per Share (MRQ) i₹214.21₹24.62

Financial Statements Comparison: Sastasundar Ventures Ltd. vs Dipna Pharmachem Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSASTASUNDR (2025)DPL (2025)
Revenue/Sales i10.90B1.25B
Cost of Goods Sold i10.20B1.14B
COGS % of Revenue i93.6%91.0%
Gross Profit i699.73M111.90M
Gross Margin i6.4%9.0%
Research & Development iN/AN/A
Operating Income (EBIT) i-644.41M40.07M
Operating Margin i-5.9%3.2%
EBITDA i-349.77M38.19M
EBITDA Margin i-3.2%3.1%
Pre-Tax Income i-2.04B14.20M
Pre-Tax Income % of Revenue i-18.7%1.1%
Income Tax i-701.22M4.47M
Income Tax % of Revenue i-6.4%0.4%
Net Income (Profit) i-1.34B9.73M
Profit Margin i-12.3%0.8%

Balance Sheet & Liquidity Metrics

MetricSASTASUNDR (2025)DPL (2025)
Cash & Equivalents i124.22M4.26M
Total Current Assets i5.80B1.32B
Total Current Assets % of Revenue i53.2%105.9%
Total Current Liabilities i980.20M849.96M
Total Current Liabilities % of Revenue i9.0%68.0%
Long-Term Debt i6.50M88.90M
Long-Term Debt % of Revenue i0.1%7.1%
Total Shareholders Equity i8.65B384.93M
Retained Earnings i3.66B31.22M
Retained Earnings % of Revenue i33.6%2.5%
Property, Plant & Equipment i99.77M489,000

Cash Flow Statement Comparison

MetricSASTASUNDR (2025)DPL (2025)
Operating Cash Flow i-124.30M-92.83M
Operating Cash Flow % of Revenue i-1.1%-7.4%
Capital Expenditures i-100.71M-201,000
Free Cash Flow i-276.65M-92.15M
FCF Margin i-2.5%-7.4%
Debt Repayment iN/A-36.57M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSASTASUNDRDPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i31.81M24.05M
Float Shares i6.23M11.37M
% Held by Insiders i80.70%51.68%
% Held by Institutions i1.15%0.00%
% Held by Public i18.15%48.32%

Dividend Analysis & Yield Comparison: Sastasundar Ventures Ltd. vs Dipna Pharmachem Ltd.

MetricSASTASUNDRDPL
Last 12-Month Dividend i₹0.00₹5.00
Last 12-Month Dividend Yield iN/A23.16%
3-Year Avg Annual Dividend i₹0.00₹6.00
3-Year Avg Dividend Yield iN/A1.72%
3-Year Total Dividends i₹0.00₹18.00
Ex-Dividend DateN/AAug 13, 2024